Company Encyclopedia
View More
name
Wise PLC Class A
WISE.UK
News
View More

From yen rushes to tariff tantrums: How geopolitical drama drove Singapore’s 2025 FX frenzy

In 2025, Singaporeans actively engaged in foreign exchange conversions due to geopolitical volatility and trade policy shifts. Multi-currency wallets like YouTrip, Revolut, and Wise reported significant increases in conversion volumes. The Japanese yen, US dollar, and Australian dollar were key targets, influenced by political events and trade tensions. Singaporeans are increasingly strategic in currency conversions, responding quickly to favorable rates. This trend is expected to continue into 2026, driven by inflation and global political cycles, with USD and JPY remaining closely watched currencies.

Businesstimes·
UK
WISE
0.00%
Businesstimes·
UK
WISE
0.00%

Wise Integration, Powernet and KEC sign MoU to co-develop SMPS solutions for AI server power supplies in Korea

Wise Integration, Powernet, and KEC have signed a MoU to co-develop next-gen SMPS solutions for AI server power supplies in South Korea. This partnership supports South Korea's AI infrastructure expansion, with Wise providing GaN power devices, Powernet leading SMPS design, and KEC handling manufacturing. The collaboration aims to enhance AI server power efficiency and accelerate market entry, aligning with South Korea's AI data center development goals.

SemiConductor·
UK
WISE
0.00%
SemiConductor·
UK
WISE
0.00%

04:00 ET NTC, con el respaldo de Wise Equity, completa la adquisición del negocio de oftalmología de Pharmathen

NTC S.r.l., supported by Wise Equity, has completed the acquisition of Pharmathen's ophthalmology business. This strategic move enhances NTC's glaucoma portfolio, boosting its competitive position in the European eye care market and expanding its international presence, including the U.S. market. The acquisition aligns with NTC's long-term ambition to offer a comprehensive ophthalmic portfolio, achieving €100 million in revenue, with over 80% from ophthalmology. The deal strengthens NTC's role in treating glaucoma, a chronic disease affecting millions globally.

prnewswire·
UK
WISE
0.00%
prnewswire·
UK
WISE
0.00%

Wise (LON:WISE) Stock Price Up 0.1% - Still a Buy?

Wise plc (LON:WISE) shares rose 0.1% to GBX 877 on Tuesday, with a trading volume significantly lower than average. Analysts have mixed ratings on the stock, with a consensus rating of 'Hold' and a target price of GBX 1,352.50. The company has a market cap of £8.86 billion and a P/E ratio of 22.07. Insider David Wells sold 100,000 shares recently. Wise provides cross-border and domestic financial services globally.

Market Beat·
UK
WISE
0.00%
Market Beat·
UK
WISE
0.00%

Wise Financing plc Issues £250 Million Notes to Bolster Global Expansion

Wise Financing plc has issued £250 million in notes under its Euro Medium Term Note Programme at a 5.1000% interest rate due in 2030. This move aims to enhance Wise's financial flexibility and support its global expansion. Analysts rate Wise PLC Class A stock as a Buy with a £1375.00 price target. Despite strong financial performance and strategic growth initiatives, high operational costs and bearish technical indicators present challenges.

Tip Ranks·
UK
WISE
0.00%
Tip Ranks·
UK
WISE
0.00%
Posts
View More

Recursion Pharmaceuticals (RXRX) $Recursion Pharmaceuticals(RXRX.US) In-depth Research Report: From Phenotypic Screening to Vertical Integration—Revaluation After Exscientia Acquisition and the New Pa......

  • 0
© 2025 Longbridge｜Disclaimer